Allegra is used for seasonal allergy symptoms and chronic hives. Its active ingredient, fexofenadine, helps relieve sneezing, runny nose, itchy eyes, and hives by blocking peripheral histamine H1 receptors. It is designed to provide symptom control with little effect on alertness at standard doses.
Fexofenadine, the active ingredient in Allegra, is a second-generation antihistamine for seasonal allergic rhinitis and chronic idiopathic urticaria. It relieves sneezing, runny nose, itchy eyes, and hives by blocking peripheral histamine H1 receptors with little effect on alertness at standard doses.
The dose of Allegra is decided individually, taking age, other medicines, kidney function, and health conditions into account. The tablet is taken by mouth with water and swallowed according to the prescribed schedule.
Common clinical dosing patterns for fexofenadine vary according to age, indication, and tablet strength. Adults and adolescents may receive once-daily or twice-daily treatment, while children require age-appropriate formulations and instructions. The correct strength matters because adult tablets should not be treated as interchangeable with paediatric products.
Key administration points include:
Kidney function can affect how long fexofenadine remains in the body. A person with reduced renal function may require a different starting dose or dosing interval. Older adults may also need individual assessment because kidney function can decline without obvious symptoms.
Fruit juice is an easy detail to miss. Components in grapefruit, orange, and apple juice can interfere with intestinal transport of fexofenadine, reducing exposure to the medicine. Plain water avoids this interaction.
Children should receive a formulation and strength intended for their age group. Adult tablets should not be split, substituted, or repurposed for a child unless a prescriber has provided specific instructions.
Paediatric dosing depends on age, body size, kidney function, the allergic condition being treated, and the formulation available. Children under 18 should use Allegra only with age-appropriate medical direction, especially when symptoms are persistent, severe, or associated with breathing difficulty.
If the person taking Allegra has kidney disease, the dose should be established before regular treatment begins. The same applies when several medicines are used together, since individual factors can change the most suitable regimen.
Allegra tablets contain fexofenadine hydrochloride, a selective peripheral H1-antihistamine. Histamine is a chemical released during an allergic response. It contributes to sneezing, nasal discharge, itching, watery eyes, skin redness, and raised hives.
Fexofenadine is the active molecule. Allegra is the product name used for the tablet formulation.
Fexofenadine belongs to the second-generation antihistamine class. It blocks histamine H1 receptors on tissues involved in allergic inflammation. This prevents histamine from producing much of the itching, sneezing, swelling, and watery discharge associated with an allergic reaction.
The medicine does not work by suppressing the immune system broadly. It targets one signalling pathway involved in allergy symptoms. This means it may relieve symptoms without treating infection, asthma inflammation, or the cause of food allergy.
Its action is mainly outside the brain because fexofenadine crosses the blood-brain barrier only to a limited degree. This pharmacological profile helps explain its lower tendency to cause drowsiness than older antihistamines.
Fexofenadine is used for:
The medicine reduces symptoms rather than removing the underlying sensitivity to pollen, dust mites, mould, animal dander, or other allergens. It does not prevent future exposure reactions. Symptom control can vary with allergen levels.
Food and Drug Administration describe fexofenadine as a non-sedating antihistamine with established use in allergic rhinitis and urticaria [1].
Several practical errors can reduce the benefit of Allegra:
A missed dose should not be replaced with a double dose. Taking extra tablets can increase the chance of headache, dizziness, nausea, or other unwanted effects without reliably improving allergy control.
Aluminium hydroxide and magnesium hydroxide antacids can reduce fexofenadine absorption. Keep them at least two hours apart from Allegra.
Do not combine multiple antihistamines for the same symptoms unless a clinician has specifically directed this approach.
Allegra is NOT for you if any of these situations apply without individual medical review:
Older adults often need the same practical review. Age alone does not automatically rule out Allegra, but kidney function, blood pressure medicines, antacids, and other treatments should be considered together.
Most people tolerate fexofenadine without major problems. Reported reactions include headache, nausea, dizziness, fatigue, and mild gastrointestinal discomfort. In controlled studies, several symptoms occurred at rates close to placebo, meaning the symptom was also reported by people who did not receive the active medicine.
Possible effects include:
A low drowsiness risk is not the same as zero drowsiness. A person who is unusually sensitive, sleep-deprived, taking other sedating medicines, or unwell may feel less alert after taking an antihistamine.
Rare allergic reactions can involve facial swelling, throat tightness, wheezing, widespread rash, or difficulty breathing. Those symptoms require urgent medical attention. Severe skin reactions are uncommon but warrant immediate assessment when a rash is extensive, blistering, painful, or associated with mouth or eye involvement.
One practical detail is that dizziness may be mistaken for dehydration, low blood pressure, or poor sleep. If it appears soon after starting treatment or after a dose change, avoid driving until the effect is clear.
The World Health Organization describes antihistamines as medicines used to control histamine-mediated allergic symptoms, while product information for fexofenadine identifies headache and gastrointestinal symptoms among reported reactions [2].
| Active ingredient | Typical profile | Sedation and kidney considerations |
|---|---|---|
| Fexofenadine | Peripheral H1 blockade; commonly used once or twice daily depending on strength and indication | Low sedation potential; kidney function affects dosing |
| Loratadine | Long-acting H1 blockade after conversion to an active metabolite | Usually low sedation; liver and kidney factors may influence use |
| Cetirizine | H1 blockade with generally rapid symptom relief | Drowsiness occurs more often than with fexofenadine; renal function matters |
Fexofenadine is relatively hydrophilic and has limited penetration into the central nervous system. Cetirizine may cause more noticeable sleepiness in some people, even though it is also classified as a second-generation antihistamine. Loratadine is usually non-sedating at standard doses, though individual responses vary.
The preferred option depends on the symptom pattern, kidney and liver health, concurrent medicines, previous response, and the need for daytime alertness. Switching between antihistamines without a clear plan can make it difficult to identify which medicine is helping or causing a reaction.
A person who develops sleepiness with one antihistamine may respond differently to another. Conversely, a person who feels alert with fexofenadine should still assess their own response before driving or operating machinery.
In clinical practice, physicians usually judge Allegra by symptom control across the day rather than by whether every symptom disappears immediately. Reduced sneezing with continued congestion may indicate that the nasal inflammation needs a different treatment approach or that allergen exposure remains high.
A doctor will often review:
Persistent hives deserve a separate assessment when they continue for weeks, recur without a clear trigger, or involve swelling beneath the skin. Allergy symptoms with wheezing or chest tightness also require evaluation beyond antihistamine treatment.
Persistent symptoms may reflect continued allergen exposure, severe nasal inflammation, an incorrect dosing schedule, or a different diagnosis. Do not take extra tablets or combine antihistamines without a treatment decision based on your symptoms and other medicines. Health Canada product information reviewed in 2024 supports assessing the indication, dose, kidney function, and interactions when response is inadequate.
Fexofenadine has a low potential for central nervous system sedation, but dizziness or fatigue can occur in some people. Assess your individual response before driving or operating machinery, especially after the first dose or after adding another medicine. The European Medicines Agency’s antihistamine safety framework, updated in 2023, supports distinguishing low-sedation medicines from a guarantee of zero impairment.
Mention kidney disease, pregnancy, breastfeeding, previous reactions to antihistamines, antacid use, and all medicines that may cause drowsiness. Describe whether symptoms involve hives, facial swelling, wheezing, fever, or persistent nasal blockage. FDA prescribing information reviewed in 2025 identifies renal function and concomitant medicines as relevant factors in selecting and using fexofenadine.
The best time depends on the prescribed schedule and when allergy symptoms occur. A once-daily dose is often taken at a consistent time, while a twice-daily schedule should be spaced as directed. Clinical guidance from the British National Formulary in 2024 supports regular timing and water administration, with attention to interactions from fruit juice and mineral antacids.
A known allergy to fexofenadine or any tablet ingredient rules out its use. Severe kidney impairment does not always prohibit treatment, but it can require a different starting dose or interval selected by a clinician. The European Medicines Agency’s product-safety principles from 2022 support individual review when renal clearance or hypersensitivity is a concern.
Children and adolescents should use an age-appropriate formulation and dose. Adult tablets should not be given to a child simply because the child has similar symptoms to an adult. Paediatric use should follow the relevant Health Canada directions from 2024 and account for age, kidney function, formulation, and the condition being treated.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
I took one tablet daily for the spring pollen season and noticed much less sneezing and eye watering after the first few days. I stayed focused during work and was satisfied with the daytime relief after using it for three weeks.
I took one tablet daily for two weeks. Allegra reduced my hives, but the improvement was slower than I expected and was not complete every day. I also noticed mild stomach discomfort at first, although it passed.
I took one tablet daily for recurring seasonal symptoms and found that my nose was calmer during outdoor activities. The tablet fitted easily into my morning routine, and I was pleased that I could concentrate normally after using it for a month.
I took one tablet daily during a difficult allergy period. Allegra helped with sneezing and itchy eyes, and I appreciated being able to use it for three weeks without feeling noticeably sleepy during the day.
